By Raluca Baciu, Vias Digital. Published 17 November 2026.
Last updated: 17 November 2026
A life science marketing agency helps a biotech, diagnostics, research tools or other life science company win business from people who check everything: scientists, lab directors, clinicians, hospital procurement, distributors and partners. They read the data before the headline. Many of them will be in the room when the decision is made, and the sales cycle can run longer than a budget year.
Vias Digital is an executive thought leadership and strategic communications agency for established B2B companies in Europe and the United States. For life science and healthtech companies we work on the position the company wants to own, the voice of the leaders who carry it, and the market and competitor picture behind every claim. Our founder, Raluca Baciu, grew organic traffic by 36% at a Swiss-American health tech company.
It does the same core jobs as any B2B marketing agency, adjusted for buyers who are trained to doubt. The parts that matter most:
Positioning that a scientist accepts. One clear statement of what the company does better, for whom, and the evidence behind it. Vague promises lose a scientific audience in the first line.
Scientific and technical content. Application notes, webinars, posters turned into readable articles, comparison pages and buyer guides that answer the questions a lab or a clinical team asks before it talks to sales.
Executive and expert voice. Points of view from the CEO, the CSO or the head of commercial, published on LinkedIn, at conferences and in trade media. In life science, people buy from experts they have heard before. Our [executive thought leadership](/executive-thought-leadership) work sits here.
Claims built for review. Every statement written so it can pass your medical, legal and regulatory review the first time, with the source attached.
Events and partner marketing. Conferences, scientific meetings and distributor programs still open many doors. The agency should plan what happens before and after the booth, not only the booth.
Reporting against pipeline. Meetings with target accounts and opportunities created, not only downloads and impressions.
In life science, a sentence that would be routine in software can need approval. What you may say about performance, outcomes or intended use depends on the product, its status and the market. That changes three things about how an agency should work.
First, the agency writes from approved evidence: the label, the published data, the approved claims list. It does not write first and hope review will fix it. Second, it plans review time into the calendar, so a campaign does not miss a conference because the review queue was full. Third, it keeps a library of approved wording, so the next piece starts from what already passed.
Ask any agency how it handles your medical, legal and regulatory review before you see a single creative idea. The answer tells you whether it has done this before. We do not give regulatory advice; your own reviewers decide what can be said.
Rarely one. A typical decision involves several people who care about different things, and the marketing has to give each of them a reason to say yes.
Scientists and lab leaders. They want data, method and a fair comparison with what they use today.
Clinical and medical teams. They want evidence, workflow fit and what changes for patients or staff, within what the product is approved for.
Procurement and finance. They want total cost, contract terms, supply security and support.
Executives and partners. They want to know the company will be around, is credible in its field and has a point of view on where the field is going.
Content written for only one of these readers leaves the others to make up their own minds, usually with a competitor's material.
Question 1: Who on the team can read our science? Ask who will write about your product and what they have written in your field. A writer who cannot read a methods section will produce copy your scientists rewrite.
Question 2: How do you work with our medical, legal and regulatory review? Ask for the process, the timeline and how they keep approved wording. If the question surprises them, keep looking.
Question 3: How will you reach the whole buying group? Ask for a plan that names each role in the decision and what each one needs to see.
Question 4: How do you work across countries? Rules, buyers and trade media differ between the US, Germany, France and the rest of Europe. Ask who adapts the content in each market.
Question 5: Which numbers will you report against pipeline? Agree on three numbers before you start, such as meetings with target accounts, opportunities that started with marketing and the time from first touch to proposal.
A biotech marketing agency focuses on companies that develop therapies, platforms or tools, and usually sells to researchers, partners and investors as much as to buyers. A B2B healthcare marketing agency works for companies that sell products and services to hospitals, clinics and health systems. A life science marketing agency often covers both, plus diagnostics and research tools.
The label matters less than the fit. Check which of your buyers the agency has written for, and whether it has worked with companies at your stage and size. If you sell devices, our guide to medtech marketing agencies covers the differences there.
Hire in-house when marketing is a permanent, full-time need in one market and you can find the person. Choose an agency when you need production capacity across content, campaigns and events. Choose a fractional CMO when you need senior judgement for part of the week: someone who sets the position, owns the plan and holds the agency to it.
Many established life science companies combine the three: a small internal team that knows the science, a senior outside lead and an agency for the peaks. Our guides to manufacturing marketing agencies and logistics marketing agencies cover the same decision in other technical sectors.
Your buyers compare you with a competitor's latest data, a new entrant's price or a regulatory change you have not yet answered. Marketing that does not know this answers last year's questions.
A short weekly briefing on what competitors, regulators and customers just did keeps the leadership team and the marketing plan current. That is what our market intelligence service delivers.
Tell us where you sell, who decides and what your claims review allows. In one call we look at what your buyers need to believe, what to keep in-house and where senior outside capacity would help most. You leave with a clear next step, whether or not we work together.
B2B marketing agency: how to choose one, what an agency does and the five questions to ask before you sign.
Manufacturing and industrial marketing agency, marketing for long cycles, technical buyers and several countries.
B2B content marketing agency, content that sells to a buying committee, and how to judge an agency.
B2B marketing consultant, consultant, agency, fractional CMO or hire: which fits.
Fractional CMO services, senior marketing leadership for part of the week.
B2B PR agency, the earned-media side of the same decision.
B2B brand strategy, the position every campaign should carry.
Medtech marketing agency, clinicians, procurement and regulated claims.
Logistics marketing agency, shippers, tenders and proof of reliability.
Content marketing agency, what to expect from one, and how to choose.
It plans and runs the marketing that helps a biotech, diagnostics, research tools or other life science company win business: positioning, scientific and technical content, executive voice, events, campaigns and reporting against pipeline, all built so claims pass your own review.
The buyers are trained to doubt, the decision is shared by scientists, clinicians, procurement and executives, and many statements need medical, legal or regulatory review before they can be published. The agency has to plan for all three.
No. A good agency writes from your approved evidence and works inside your review process. What can be said about a product is decided by your own medical, legal and regulatory reviewers.
You need an agency that can read your science and has written for your buyers. Specialist experience helps with vocabulary, events and trade media. It does not replace understanding why your customers choose you over the alternative.
Expect the first quarter to go into positioning, approved wording and content, with early signals such as better-qualified conversations. The effect on pipeline shows over a full sales cycle, which in life science often runs many months.
Meetings with target accounts, opportunities that started with or were helped by marketing, the time from first touch to proposal, and which content buyers mention in sales conversations. Downloads and impressions are signs of activity, not results.
Yes. We work with established B2B companies in Europe and the United States, including companies entering new markets on either side of the Atlantic.
One 20-minute call with us. We go through your story and your proof, and tell you where we would start.
You speak directly with us.